IMS site is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Joint Secretary, Department of JusticeMinistry of Law & Justice Government of India
Joint Secretary, Department of Justice
Ministry of Law & Justice Government of India
Mr. G.R. Raghavender is a civil servant from Central Secretariat Service (CSS) 1988. At present he is Joint Secretary, Department of Justice, Ministry of Law & Justice since January 2017. He is Mission Director for the National Mission for Justice Delivery and legal reforms. He is driving policy reforms for improving Enforcing Contracts parameter under the ease of doing business and eCourts project. Earlier, he was Joint Secretary in Department of Industrial Policy and Promotion, Ministry of Commerce & Industry, Government of India, New Delhi. There, he also held additional charge of Director General, National Productivity Council (NPC) from Dec 2015 to May 2016. Mr. Raghavender is a former Registrar of Copyrights of the Indian Copyright office. He played a key role in introduction of the recent amendments to the Copyright Act in 2012 and the Copyright Rules, 2013. He attended many WIPO SCCR meetings
and FTA negotiations as a member of Indian delegation. He made significant contributions to recently concluded two WIPO treaties namely, Beijing Treaty on Audiovisual Performances, 2012 and the Marrakesh Treaty to Facilitate Access to Published Works for Persons Who Are Blind, Visually Impaired, or Otherwise Print Disabled, 2013. He has contributed in revision of the copyright legislations of Bhutan, Kampuchia, Myanmar and Nepal as a copyright expert. As a resource person he gives lectures/talks on Copyrights and Related Rights in various International and National seminars and workshops organized by WIPO and by several Law Schools, Universities and Institutes all over India.
At present he is pursuing PhD(IPRs) from GGSIP University, New Delhi.He holds several degrees and post graduate degrees namely, M.A. Development Studies (Public Policy& Management) from Institute of Social Studies (ISS), the Hague, the Netherlands. M.A.(Gold medallist) &M.Phil (Ancient History.& Archaeology) from Osmania University, Hyderabad. Mr. G.R. Raghavender holds a LLB degree from Delhi University and LL.M (IPRs) from GGSIP University, New Delhi.
Global IP HeadIntas Pharmaceuticals Limited
Vice President & Head – Intellectual PropertyDr. Reddy’s Laboratories
Vice President – IPMMacleods Pharamceuticals Limited
Global IP Head
Intas Pharmaceuticals Limited
Vice President & Head – Intellectual Property
Dr. Reddy’s Laboratories
Vice President – IPM
Macleods Pharamceuticals Limited
Member and Registered Patent AttorneyCozen O’Connor
Co-Chair, Intellectual Property LitigationCozen O’Connor
FounderAppropriate IP Services
Co-Chair Hatch-Waxman and Biologics Litigation Group, Registered Patent AttorneyCozen O'Connor
PartnerMaynard Cooper and Gale
Head - IPM & Patent CounselUnichem Laboratories Limited
Regional Vice President of National AccountsXact Data Discovery
PartnerArent Fox LLP
Former Chief JudgeU.S. District Court, New Jersey
Associate DirectorKashiv Biosciences Pvt. Limited, Formerly Adello Biologics
DirectorSterne, Kessler, Goldstein & Fox P.L.L.C.
PartnerGreenblum & Bernstein, P.L.C., USA
Director (Head) - IPM Fresenius Kabi Oncology Ltd
Partner and Co-ChairGoldberg Segalla
Head- Pharmaceuticals and Life SciencesTaft
Senior In-House Patent AttorneyIndoco Remedies Limited
Vice President – National AccountsXact Data Discovery
Partner Lerner David
CounselMaynard Cooper and Gale
Member and Registered Patent Attorney
Aaron Lukas is a registered patent attorney who concentrates his practice on complex patent cases for clients in the pharmaceutical, biotechnology, and semiconductor industries. Aaron has handled all aspects of cases including pre-suit investigations, fact and expert discovery, dispositive motions, and trial. He also has experience in IPR matters at the PTAB on behalf of both patent owners and challengers. In addition to patent litigation, his practice includes representing clients seeking patentability, infringement, and invalidity analyses, as well as developing strategic plans for clients seeking to protect their intellectual property around the world. Aaron has worked with clients in a wide range of high technology fields, including nanotechnology, semiconductor devices, display technologies, gene synthesis, recombinant DNA technology, diagnostic assays, and pharmaceuticals.
Aaron Eckenthal has specialized in all varieties of intellectual property litigation from the outset of his career. One area of focus includes ANDA and Hatch-Waxman litigation where he has represented several generic drug companies. In addition to life science based litigation, Aaron has litigated other cases that involve complex patent, trademark and copyright issues. His work spans a variety of technical areas including chemical, pharmaceutical, food science, medical device, and biotechnology.Aaron is also active in inter partes review (IPR) proceedings. He has extensive experience with patent and trademark procurement and has assisted clients in developing strong patent and trademark portfolios in an effort to achieve business and intellectual property goals. Some of Aaron’s success for clients can be attributed to his strong business acumen – his focus on big picture business goals to create a meaningful business strategy through intellectual property that will accomplish the overall objective for a client. Aaron obtained hisMasters in Biology from Rutgers University, after studying Bacteriology and Genetics at the University of Wisconsin. AaronEckenthal was recently recognized as a
Rising Star in Intellectual Property by New Jersey Super Lawyers Magazine.
Dr. Alpesh Pathak is currently Vice President - Global IP Head at Intas Pharmaceuticals Ltd. Dr. Alpesh has also written two books Entitled “Protecting Patent Fundamentals” and “Understanding Global patent litigations through landmark judgements – A litigation ready reckoner” (just published) which is well appreciated in patent professionals and major universities wherein patent is one of the value-added subjects in the respective technical discipline.
Having spent more than two decade in the field of IP, he works on a variety of intellectual property matters at Intas at Global Level, including IP due diligence of Biosimilar, IP activities for 351(k) filing, FTF Para IV filing, handling patent litigations across the globe and related activities. He is also responsible for drafting and prosecution of patent applications, drafting and negotiation of intellectual property agreements with third parties, and due diligence analyses in supporting in-licensing and out-licensing activities.
Prior to joining Intas, Dr. Pathak has worked with some of the leading pharmaceutical companies like Alembic Ltd, Lupin Ltd., Zydus Cadila and Cadila Pharmaceuticals. He holds a PhD degree from The Sardar Patel University. He is a registered Patent agent. Besides having PG diploma in Patent Law degree from Nalsar Uni, Hyderabad, he has undergone various specialized courses on US litigations and European patent practices. He has completed Masters and Bachelors in Science from the Sardar Patel University with specialization in organic chemistry. Dr. Alpesh is also active in certain
knowledge development programs for creating IP awareness by conducting lectures in various universities and conferences in India and abroad. He is also currently a visiting faculty at Sardar Patel University and Gujarat Technical University (GTU).
Dr. Alpesh Pathak has contributed as speaker in more than 90 leading IP conferences/Seminars/workshop across the globe.
Co-Chair, Intellectual Property Litigation
Barry Golob focuses his practice on complex patent litigation. He is an experienced first-chair trial attorney with extensive federal jury and bench trial experience, having led trial teams in more than 90 cases, many of which were tried to verdict. Although Barry has represented clients at all levels of litigation in various fields of technology, including computer software, medical devices, office furniture, the Internet, insurance, manufacturing, LEDs and telecommunications, he presently focuses on consumer electronics and Hatch-Waxman litigation. In addition to handling complex jury and bench trials nationwide and appeals before the
States Court of Appeals for the Federal Circuit
, he has participated in all aspects of alternative dispute resolution, including arbitrations and mediations. In this regard, Barry Golob has also developed innovative approaches and strategies to resolve significant disputes to avoid costly litigation, and often lectures on these topics.
Appropriate IP Services
Dr. Bharati Nadkarni has 20 years of experience with:
Dr. Nadkarni joined Sun Pharmaceutical Industries Limited as an executive of IP Cell and later as Global Vice President - IP and Portfolio Planning. She was responsible forproduct identificationin the regulated markets, and IP strategy &litigation for all markets. She provided support across functions for filing and launch of products in view of IP strategy. Recently he has founded a firm Appropriate IP Services to provide IP and Business development consultancy to pharma industry clients. The firm works closely with the client, as an extension of their in-house teams, to provide inputs on product identification and IP strategy. We have experience in the areas of IP, Business development and Regulatory science, and provide a unique value to the client in working from product identification to product launch, and everything in between.
Co-Chair Hatch-Waxman and Biologics Litigation Group, Registered Patent Attorney
Blake Coblentz focuses his practice on patent litigation and counseling for clients in the biotechnology and pharmaceutical industries. A registered patent attorney, Blake has deep subject-matter knowledge in the areas of biochemistry, molecular and cellular biology, gene synthesis, recombinant DNA technology, immunology, pharmaceuticals, therapeutic methods, diagnostic assays, and vaccines. He counsels pharmaceutical companies in the areas of Paragraph IV design strategies, Hatch-Waxman litigation, and biosimilar market opportunities. Blake is not just a litigator; he’s a trial lawyer. His ability to bring clarity to complex issues through effective depositions and examinations of witnesses have led to significant victories for his clients. Blake’s notable trial wins in the pharmaceutical sector include a favorable decision of non-infringement in the first ever case to go to trial under the Biologics Price Competition and Innovation Act and the only successful defense to date of patents
on a transdermal testosterone product. Blake also represents patent owners and challengers in inter partes reviews before the Patent Trial and Appeal Board.
Maynard Cooper and Gale
Brandon Stroy is a partner in the Firm’s Intellectual Property & Technology practice. His practice is centered on intellectual property counseling, litigation, and diligence. Brandon’s background in Electrical and Biomedical Engineering enables him to advise clients across a range of complex technological areas. He has tried patent cases relating to pharmaceuticals, medical devices, computers, and software. He also advises clients on strategic and business issues related to intellectual property, including portfolio management and valuation and licensing. Over the course of his career, Brandon has defended some of Silicon Valley’s most prominent technology companies on patent matters. He has successfully represented clients in a variety of intellectual property matters including the Internet, data networking, encryption technologies, telecommunications, electrochemical sensors, semiconductors, medical devices, and automotive technologies. He also has extensive experience litigating intellectual property cases for life sciences companies, including Hatch-Waxman/ANDA litigation.
Brandon has also represented clients in matters before the United States Patent and Trademark Office, including post-grant proceedings under the America Invents Act. He was named a Northern California Rising Star for Intellectual Property and Intellectual Property Litigation by Super Lawyers in 2016 and 2017. Brandon Stroy received his J.D. from Columbia University along with M.E.M. and a B.S from Duke University.
Head - IPM & Patent Counsel
Unichem Laboratories Limited
Mr. Gautam Bakshi, is an IP Attorney, currently working as HEAD - Intellectual Property Management & Patent Counsel with an Indian Multinational Pharmaceutical Company, Unichem Laboratories Limited.
He is an experienced Intellectual Property Management professional with a demonstrated history of working in the management position in the pharmaceutical industry with proven track record. Skilled in Strategy, Management & Enforcement of IP coupled with strong leadership capabilities nurtured with Management Development Programmes focused in Leadership Excellence from Top B-schools like Indian Institute of Management (IIM-C), XLRI & MDI.
Mr. Bakshi has rich expertise in the field of IP. His main areas of interest include Identification, Analysis and Management of IP. He is also well versed with the art and skill of IP Prosecution, Litigation. Licensing, Settlements and subsequent procedures thereof.
Mr. Gautam has previously worked as Head IP for:
He was also associated in past with Dr. Reddy's Laboratories & Torrent Pharma.
He has several Patent Applications as an inventor to his credit filed globally. Mr. Gautam Bakshi has number of publications, has been Guest Faculty for many Institutes, been a panelist and an expert speaker in large number of seminars and workshops on IP rights and education, in India and overseas.
Regional Vice President of National Accounts
Xact Data Discovery
Jane Funk is the Regional Vice President of National Accounts for Xact
Data Discovery based in Chicago. Jane assists clients on a national basis,
with eDiscovery, managed review and consulting needs.
Jane brings over 11 years of experience in the legal industry. She was
ranked #1 globally for Chairman’s Club and pioneered the managed
review practice at a prominent legal staffing as the first Director of Legal
Project. She was promoted to VP of Consulting Services where she
worked nationally in assisting in-house legal departments and law firms
in all aspects of eDiscovery, managed review, information governance,
records management, contracts management, mergers and acquisitions,
internal investigations, government investigations, data privacy, cyber security, and compliance and
regulatory initiatives. Prior to her executive consulting roles, Jane practiced in litigation for a Chicago
based firmed, Gardiner Koch Weisberg & Wrona. Her practice was focused in commercial and real estate
Arent Fox LLP
Dr. John Hanish is a Shareholder in Maynard Cooper’s New York office and a member of the firm’s Intellectual Property Litigation and Intellectual Property Protection practice groups. He started his legal career at Fish & Neave and has 18 years of experience in the trial and appeal of patent licensing and infringement matters in the federal courts, International Trade Commission and arbitration. He also practices in the U.S. Patent and Trademark Office with respect to filing petitions and conducting proceedings for post-grant review, inter partes review and the transitional program for covered business method patent review. He also assists clients with patent prosecution and opinions regarding patent infringement and validity.
Dr. John’s doctorate and research experience help him assist clients with patent issues in the life sciences. He also has extensive experience with medical device, consumer product, technology and software patents. Before he attended law school, Dr. John Hanish was a Winston Fellow at The Rockefeller University and a Research Scientist at the Sloan-Kettering Institute.
Former Chief Judge
U.S. District Court, New Jersey
The Honorable Jose L. Linares served as Chief Judge of the United States District Court for the District of New Jersey, having been nominated to the bench by President George W. Bush in 2002. He is highly experienced in the life sciences and financial services industries, having heard numerous patent cases in the past sixteen years - many involving high-stakes disputes between generic and branded drug companies. An acknowledged thought leader, Judge Linares lectures nationally on litigation and patent cases. He has served as an adjunct professor at Seton Hall School of Law. He led the
New Jersey District Court 2017 Sentencing Symposium and the 2018 New Jersey District Court National Opioid Symposium. He is a fellow of the American Bar Association. Judge Lineras has been honored with the New Jersey State Bar Distinguished Judicial Service Award and the James J. McLaughlin Professionalism Award presented by the New Jersey State Bar Association and is also the recipient of several lifetime achievement awards.
Kashiv Biosciences Pvt. Limited, Formerly Adello Biologics
Lawrence is a Partner in our Chemistry, Biotechnology and Pharmaceuticals patent department. Lawrence previously worked in-house within the Intellectual Property Department of GlaxoSmithKline for eight years, and is particularly valued by clients for his understanding of the role of in-house counsel and the commercial application of intellectual property in the life sciences field. Lawrence’s existing practice includes drafting and prosecuting patent applications for a broad range of technologies on a worldwide basis. Lawrence also has considerable experience of providing strategic advice in respect of patent infringement and validity, handling patent opposition matters, and undertaking due diligence assessments of third party IP for licensing and acquisition purposes.
A selection of Lawrence’s key clients include:
Lawrence was recently described in Legal 500 UK as being “very knowledgeable both in Chemistry and in IP law”.
Dr. Mahalaxmi Andheria brings with her an experience of more than 20 years in the Pharma & Biotech Industry. She has been actively involved in formulation R&D for 5 years and thereon worked on IPR. Dr. Andheria is a PhD in Pharmaceutics from ICT (former UDCT, Mumbai) and a Post-Doctorate from University of Cincinnati, USA. She started her IPR career with Sun Pharma, while her association with Panacea Biotec for 13 years was instrumental in forming and managing the IPR Department consisting of specialists in diverse fields including biological (vaccines and biosimilars), pharmaceutical & synthetic chemistry area. During her tenure at Panacea, she established a seamless collaboration with Business Development and R&D expanding the horizon of traditional IPR by broadening the outlook into portfolio planning, strategizing innovation and business challenges through creative interdepartmental collaborations. Currently she has taken the realms of IPR at Ajanta Pharma, contributing towards the goals and aspirations of this fastest growing Specialty Pharmaceutical Company.
Dr. Andheria finds it extremely satisfying to share her understanding of this field and takeaways from her experience with students, inventors and business professionals interested in understanding the impact of IPR on their business decisions. She regularly speaks in conferences, summits, workshops. In addition she actively engages in dialogue with policy makers in an effort to contribute towards the development of a robust and balanced National IP Policy. Dr. Mahalaxmi Andheria is a Committee Member of the CII National Committee on Intellectual Property.
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Nirav N. Desai is a director in Sterne Kessler's Trial & Appellate and Electronics Practice Groups. He is experienced in a full-range of intellectual property issues, with a particular focus on patent litigation and counseling clients in general intellectual property strategy. An accomplished litigator, Nirav has served as lead counsel in district court litigation matters around the country and has been involved in matters before district courts, appellate courts, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB), and the U.S. International Trade Commission (USITC) in Section 337 actions. Nirav Desai has litigated and counseled clients in a wide range of both high tech and life science industries, from consumer electronics and software to pharmaceuticals and medical devices.
Greenblum & Bernstein, P.L.C., USA
Dr. Paul Braier is a shareholder at G&B, and a member of the Pharmaceutical; Biotechnology; Litigation and Trial; and Client Counseling practice groups of Greenblum & Bernstein. His work in these groups includes preparing and supervising preparation of infringement and validity opinions, Notice Letters, litigation, and FDA citizen petitions, as well as general counseling, particularly in the pharmaceutical, chemical, and medical arts. He is involved extensively in the firm's pharmaceutical practice, and advises drug companies (primarily generics) on strategic planning and new product introduction. He works extensively with Hatch-Waxman issues and the interface of patent and FDA law. Dr. Paul is a regular panelist in seminars given in association with the annual conferences of the Pharma IPR India conferences, and has spoken regularly at the International Generic Pharmaceutical Association and the European Generics Association and other conferences. He is an editor for the Journal of Generic Medicines and regularly contributes articles on patent law and generic drugs.
Dr. Braier received a Bachelor of Science in Chemistry with high honors from the College of William and Mary in 1986, a Ph.D. in Chemistry from the University of Chicago in 1992, and a Juris Doctor degree from the Georgetown University Law Center in 1998. While at Georgetown University, he was a staff member of the Journal of Legal Ethics.
Dr. Paul is admitted to the Virginia State Bar, the U.S. District Court and Bankruptcy Courts for the District of Columbia, and the Court of Appeals for the Federal Circuit, and is registered to practice before the United States Patent and Trademark Office. Dr. Paul Braier is a member of the American Intellectual Property Law Association, the American Bar Association, and the American Chemical Society.
Director (Head) - IPM
Fresenius Kabi Oncology Ltd
Dr. Prachi Tiwari is adoctorate in Organic Chemistry, MBA and Law graduate with several PG courses in IPR. She is a registered Indian Patent Agent with about 19 years of experience in leading pharmaceutical companies like Alembic, Ranbaxy (Presently Sun), Teva Pharma and Fresenius Kabi Oncology Ltd.
Dr. Tiwari has more than 16 years of experience as a patent professional and handled a wide sphere of technological areas of patents –chemistry, polymorph, formulations, drug delivery systems, indication, biotechnology & biosimilars and nutrition.
Currently Dr. Prachi is responsible for all the patent matters globally by supporting and advising to the Research & Development, Business and Allied Functions of the Organization. She ensures hassle free product launch and exploring early market entry opportunities by designing around and challenging road block patents/applications. She handles drafting and prosecution of more than 200 patent applications. She is successfully involved in Indian opposition / litigation of Patents/applications. Dr Prachi Tiwari workson identification of new and potential products, for the inclusion in product portfolio grid.
Dr. Ramani V Marakani has 15 years of experience in patent preparation and prosecution. She was working as a Senior Director with Clairvolex Knowledge Process Pvt. Ltd. She was mentoring patent engineers and supervising the patent development team in Bangalore to ensure high quality of patent applications. Prior to this she was a Director at Intellectual Ventures. In this role, she was responsible working with inventors from prominent Indian universities in the areas of material science, polymer chemistry and other related chemical sciences. Dr. Ramani was an Associate with Schwegman Lundberg & Woessner, Minneapolis prior
to IV. She held the positions of an IP Counsel with Philips Electronics India Ltd., and a Lead Scientist with John F Welch Technology Centre, Bangalore. Before moving to IP and R&D, she was an Assistant Professor at one of the engineering colleges in Bangalore. She received her B. Tech and M.Tech in Chemical Engineering from Osmania University, Hyderabad. She received her PhD from IISc, Bangalore. Dr. Ramani Marakani received her JD and LLM from the then Franklin Pierce Law Centre (now University of New Hampshire School of Law).
Partner and Co-Chair
Ron Daignault, partner and co-chair of Goldberg Segalla's Intellectual Property Practice, is a trial attorney with over 25 years of experience and an intellectual property litigator. Widely respected as a pharmaceutical Hatch-Waxman and Abbreviated New Drug Application (ANDA) litigator for both generic and branded drug companies. Ron has guided clients through litigation involving dozens of patents, products, formulations & designs, and methods of use. Ron has been involved in numerous bench, jury trials and
evidentiary hearings, serving as lead counsel or second chair in most of them, and has also argued before several U.S. Courts of Appeals and the New York State Appellate Division.
A frequent writer and speaker on topics in the field of intellectual property, he has held a spot on the New York Metro Super Lawyers list consistently since 2012, and Managing Intellectual Property has recognized him as a “Star” in both Life Sciences and Intellectual Property every year since 2013. Ron Diagnault currently serves as an Advisory Board member of Bloomberg/BNA's Life Sciences Lawand Industry Report and an Amicus Committee member of the New York Intellectual Property Law Association.
Sasha Rao is Chair of Maynard Cooper & Gale’s nationwide Intellectual Property Practice, which includes an experienced team of IP lawyers and professionals located in San Francisco, New York, Huntsville, and Birmingham. She is a seasoned IP lawyer and regularly leads intellectual property and commercial litigation for her clients, including cases involving patents, trademarks, copyrights, trade secrets, unfair competition, and complex commercial disputes. Her strong science background in physics has enabled her to develop effective courtroom strategies for cases involving technologies ranging from pharmaceuticals, medical devices, and biotechnology to computers, Internet, and software. In the realm of life sciences, Sasha has extensive experience in Hatch-Waxman/ANDA litigation and has represented generic and branded pharmaceutical companies in numerous patent cases.
Sasha also advises clients on corporate, transactional, policy and regulatory matters, including IP aspects of mergers and acquisitions. Her enthusiasm for cutting-edge technologies has led to her being recognized as one of the leading practitioners in the emerging ?eld of autonomy and robotics systems. She is registered to practice in the United States Patent and Trademark Office. She also represents clients in Patent Office trials, including Covered Business Method (CBM) and Inter Partes Review (IPR) post-grant invalidity challenges available under the America Invents Act.
Sasha was selected as an Intellectual Property Trailblazer for 2019 by the National Law Journal. She was also named by the Daily Journal in 2019 as one of California’s Top Women Lawyers, Top Artificial Intelligence Lawyers, and one of California’s Top Intellectual Property Lawyers. Sasha’s success and talents in the IP ?eld have also earned her recognition by The Best Lawyers in America© in the area of Litigation: Intellectual Property (2017-present). The Recorder has recognized her 4 times as one of the “Women Leaders in Tech Law.” Sasha Rao was also recognized as a “Trailblazer” by the South Asian Bar Association – Northern California (2016); an “IP Star” by Managing IP magazine (2013–2018); one of the “Top 250 Women in IP” by IP Stars (2013–2018).
Simon is a Partner in our litigation department. Prior to joining AA Thornton Simon worked in the patent litigation department of a London based IP boutique law firm and also in-house within the legal Department of Eli Lilly. Simon’s in-house experience is particularly valued by clients because it allows him to understand the commercial drivers affecting their businesses. Simon’s practice includes life sciences and pharmaceutical patent litigation across a broad range of technologies. Simon also has considerable experience of providing strategic advice in respect of product life cycle management, freedom to operate, and Supplementary Protection Certificates.
A selection of Simon’s key contentious matters include:
Head- Pharmaceuticals and Life Sciences
Senior In-House Patent Attorney
Indoco Remedies Limited
Vice President – National Accounts
Tedd Van Buskirk, a partner with Lerner David, is a business-minded and result-driven intellectual property litigator with a life sciences focus, serving clients in the pharmaceutical, medical device, and biotechnology industries. Over the past 25 years, he has earned a reputation for his ability to absorb the scientific, legal, and business implications and nuances of virtually any technologyspecifically for his knack in making them understandable to non-technical audiences, especially in the courtroom. He has a track record of success helping clients navigate the complex intersection of the patent and FDA laws relating to the Hatch-Waxman Amendments. From the earliest blockbusters to the multi-defendant FTF cases of today, Tedd has litigating ANDA cases and prosecuted parallel inter partes review (IPR) proceedingsfrom filing through trial and appeal from A to Z (ALOXI®, ANDROGEL®, CLARITIN®, EFFIENT®, INVOKANA®/INVOKAMET®, LIDODERM®, NEURONTIN®, OXYCONTIN®, PREVACID®, PRECEDEX®, PRILOSEC®, TRINTELLIX®, ZANTAC®, and ZOFRAN®, among others).Prior to joining Lerner David, he was a partner in several AmLaw 100 firms.Tedd Van Buskirk is a frequent panelist and speaker on Hatch-Waxman matters and is often quoted in the press and published on issues affecting the pharmaceutical industry.
For 40 years, Edward Bailey has focused his practice on intellectual property litigation including patents, trademarks and copyrights. He is an experienced trial lawyer, having tried cases (both jury and bench trials) in numerous jurisdictions. Ed also has had experience in the United States Court of Federal Claims and the International Trade Commission. He is registered to practice in the United States Patent & Trademark Office and has represented clients in contested proceedings in that office.